Targeting the HER-kinase axis in cancer

This publication has 62 references indexed in Scilit:

• Erlotinib (Tarceva): An update on the clinical trial program
  Seminars in Oncology, 2003
• Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 2001
• Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents
  Oncogene, 2001
• The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
  International Journal of Gynecologic Cancer, 2001
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Epidermal Growth Factor Receptor Family and Chemosensitization
  JNCI Journal of the National Cancer Institute, 1997
• Prevalence and Significance of HER-2/neuAmplification in Epithelial Ovarian Cancer
  Gynecologic and Obstetric Investigation, 1995
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells
  Science, 1984
• Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
  Nature, 1984